Biotech Startup Investment Held Steady Even As AI Funding Surged

Biotech startup funding remained steady around $36-$40 billion globally in 2026 despite a surge in AI investments. AI-focused biotechs raised over $6 billion, with Isomorphic Labs leading at $2.1 billion. Most biotech funding is early-stage, with many companies opting to go public after Series B or C rounds.